Interleukin-6 in cerebrospinal fluid as a biomarker of acute meningitis

Annals of Clinical Biochemistry

Volumn 53, Issue 1, 2016, Pages 155-163

  García Hernández, Pablo ^a   Prieto, Belén ^a   Martínez Morillo, Eduardo ^a   Rodríguez, Verónica ^a   Álvarez, Francisco V ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

cerebrospinal fluid; interleukin 6; Meningitis; sensitivity; specificity

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHEMOLUMINESCENCE; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ELECTROCHEMILUMINESCENCE; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; VIRUS MENINGITIS; ACUTE DISEASE; CEREBROSPINAL FLUID; INFANT; MENINGITIS; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-6; MALE; MENINGITIS; MIDDLE AGED; YOUNG ADULT;

EID: 84950312173     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563215589381     Document Type: Article

References (36)

1. A.R.TunkelB.J.HartmanS.L.Kaplan. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis2004; 39: 1267–1284.
2. L.J.BaraffS.I.LeeD.L.Schriger. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J1993; 12: 389–394.
3. H.M.WuS.M.CordeiroB.H.Harcourt. Accuracy of real-time PCR, Grain stain and culture for Streptococcus pneuomiae, Neisseria meningitides and Haemophilus influenza meningitis diagnosis. BMC Infect Dis2013; 22: 13–26.
4. E.TaskinM.TurgutM.Kilic. Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis. Mediators Inflamm2004; 13: 269–273.
5. B.NegriniK.J.KelleherE.R.Wald. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics2000; 105: 316–319.
6. NCCLS. Body fluids analysis for cellular composition: proposed guideline [NCCLS document H56-P, ISBN 1-56238-575-5]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania: NCCLS, USA, 2003
7. P.C.HeinrichI.BehrmannS.Haan. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J2003; 15: 374: 1–20.
8. A.R.GoepfertW.W.AndrewsW.Carlo. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol2004; 191: 1375–1381.
9. F.DeisenhammerA.BartosR.Egg. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol2006; 13: 913–922.
10. G.KenisC.TeunissenR.De jongh. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine2002; 19: 228–235.
11. B.PrietoD.MiguelM.Costa. New quantitative electrochemiluminiscence method (ECLIA) for interleukin-6 (IL-6) measurement. Clin Chem Lab Med2010; 48: 835–838.
12. W.A.Bonadio. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J1992; 11: 423–431.
13. A.R.TunkelW.M.Scheld. Issues in the management of bacterial meningitis. Am Fam Physician1997; 56: 1355–1362.
14. S.G.HeckenbergM.C.BrouwerD.van de Beek. Bacterial meningitis. Handb Clin Neurol2014; 121: 1361–1375.
15. D.E.MacfarlaneV.R.Narla. Cerebrospinal fluid C-reactive protein in the laboratory diagnosis of bacterial meningitis. Acta Paediatr Scand1985; 74: 560–563.
16. J.S.AbramsonK.D.HamptonS.Babu. The use of C-reactive protein from cerebrospinal fluid for differentiating meningitis from other central nervous system diseases. J Infect Dis1985; 151: 854–858.
17. B.R.NathanW.M.Scheld. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis2002; 22: 155–165.
18. D.GendrelJ.RaymondM.Assicot. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis1997; 24: 1240–1242.
19. D.GendrelJ.RaymondM.Assicot. Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children. Presse Med1998; 27: 1135–1139.
20. M.JerebI.MuzlovicS.Hojker. Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection2001; 29: 209–212.
21. A.ViallonF.ZeniC.Lambert. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis1999; 28: 1313–1316.
22. N.ShimetaniK.ShimetaniM.Mori. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest2001; 61: 567–574.
23. H.SuS.S.ChangC.M.Han. Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis. J Perinatol2014; 34: 268–274.
24. L.ShahkarA.KeshtkarA.Mirfazeli. The role of IL-6 for predicting neonatal sepsis: a systematic review and meta-analysis. Iran J Pediatr2011; 21: 411–417.
25. D.L.GruolT.E.Nelson. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol1997; 15: 307–339.
26. J.A.VázquezM.C.AdducciC.Coll. Acute meningitis prognosis using cerebrospinal fluid interleukin-6 levels. J Emerg Med2012; 43: 322–327.
27. T.PrasadR.KapoorR.Srivastava. Cerebrospinal Fluid TNF-α, IL-6, and IL-8 in children with bacterial meningitis. Pediatr Neurol2014; 50: 60–65.
28. M.KiliçO.UlusoyS.Cirrik. Effect of exercise intensity on cerebrospinal fluid interleukin-6 concentration during recovery from exhaustive exercise in rats. Acta Physiol Hung2013; 5: 1–11.
29. D.SasayamaK.HattoriC.Wakabayashi. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res2013; 47: 401–406.
30. A.O.MukaiV.L.J.KrebsC.J.Bertoli. TNF-α and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol2006; 34: 25–29.
31. C.C.HsiehJ.H.LuS.J.Chen. Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis. Child’s Nerv Syst2009; 25: 461–465.
32. V.L.Pinto-JuniorM.C.RebeloR.N.Gomes. IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis. Braz J Infect Dis2011; 15: 156–158.
33. H.BraillyF.A.Montero-JulianC.E.Zuber. J. Total interleukin-6 in plasma measured by immunoassay. Clin Chem1994; 40: 116–123.
34. W.A.BanksA.J.KastinE.G.Gutiérrez. Penetration of interleukin-6 across the blood-brain barrier. Neurosci Lett1995; 179: 53–56.
35. W.A.BanksJ.L.LynchT.O.PriceCytokines and the blood-brain barrier. In: A.SiegelS.S.Zalcman (eds). The neuroimmunological basis of behavior and mental disorders, New York: Springer, 2009, pp. 3–17.
36. K.PrasadN.Karlupia. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews. Respir Med2007; 101: 2037–2043.